NASDAQ: XRAY · Industrial Applications and Services · 3 alerts · CIK 818479
Share price
$8.94Close, Nov 16
Market cap
$1.77B
Shares outstanding
198.15MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Dental Equipment & SuppliesSIC 3843
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Dentsply Sirona Inc. filings on SEC EDGAR ↗
For the three months ended September 30, 2026, Dentsply Sirona reported net sales of $836 million and a net loss attributable to the company of $2 million. This represents an improvement from the $427 million net loss in the prior year period, which was heavily impacted by $262 million in goodwill and intangible asset impairments.
Dentsply Sirona reported Q3 2026 net sales of $836 million, a 7.6% decrease year-over-year, and a GAAP diluted loss per share of $0.01. Despite challenging industry conditions, the company highlighted record quarterly sales for its Wellspect Healthcare segment and updated its full-year 2026 outlook.
Term
Q3 2026
“We continued to make progress on our Return-to-Growth Action Plan in the third quarter despite challenging industry-wide conditions. We are seeing encouraging signs of progress, including record quarterly sales for Wellspect Healthcare, progress in priority areas of implants and endodontics, and broader customer access through our expanded U.S. dealer network. Building on the investments we began in the first half, our focus is now on execution, putting our sales force, clinical education and innovation capabilities to work to drive consistent performance and sustainable growth.”
Dan Scavilla, President and Chief Executive Officer
Dentsply Sirona Debt Financing Update with JPMorgan Chase Bank, N.A.
DENTSPLY SIRONA Inc. entered into amendments for its revolving credit facility and three separate note purchase agreements to increase its maximum permitted leverage ratios for the second half of 2026. The amendments also include EBITDA addbacks for certain cash charges and impose temporary restrictions on new liens, subsidiary debt, and restricted payments. These changes are intended to ensure the company maintains compliance with its debt covenants through the end of the fiscal year.